User menu

Antimicrobial susceptibility of anaerobic bacteria in Belgium as determined by E-test methodology.

Bibliographic reference Glupczynski, Gerald ; Berhin, C. ; Nizet, H.. Antimicrobial susceptibility of anaerobic bacteria in Belgium as determined by E-test methodology.. In: European Journal of Clinical Microbiology & Infectious Diseases : an international journal on pathogenesis, diagnosis, epidemiology, therapy, and prevention of infectious diseases, Vol. 28, no. 3, p. 261-267 (2009)
Permanent URL
  1. Tzianabos AO, Kasper DL (2005) Anaerobic bacteria: general concepts. In: Mandell GL, Bennett JL, Dolin R (eds) Principles and practice of infectious diseases, 6th edn. Churchill Livingstone, Philadelphia, pp 2810–2816
  2. Snydman DR, Jacobus NV, McDermott LA et al (2007) National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004. Antimicrob Agents Chemother 51:1649–1655
  3. Hedberg M, Nord CE, on behalf of the ESCMID Study Group on Antimicrobial Resistance in Anaerobic Bacteria (2003) Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe. Clin Microbiol Infect 9:475–488
  4. Papaparaskevas J, Pantazatou A, Katsandri A et al (2005) Multicentre survey of the in-vitro activity of seven antimicrobial agents, including ertapenem, against recently isolated Gram-negative anaerobic bacteria in Greece. Clin Microbiol Infect 11:820–824
  5. Roberts SA, Shore KP, Paviour SD, Holland D, Morris AJ (2006) Antimicrobial susceptibility of anaerobic bacteria in New Zealand: 1999–2003. J Antimicrob Chemother 57:992–998
  6. Salonen JH, Eerola E, Meurman O (1998) Clinical significance and outcome of anaerobic bacteremia. Clin Infect Dis 26:1413–1417
  7. Nguyen MH, Yu VL, Morris AJ et al (2000) Antimicrobial resistance and clinical outcome of Bacteroides bacteremia: findings of a multicenter prospective observational trial. Clin Infect Dis 30:870–876
  8. Jousimies-Somer HR, Summanen P, Citron DM, Baron EJ, Wexler HM, Finegold SM (eds) (2002) Wadsworth anaerobic bacteriology manual, 6th edn. Star, Belmont, CA
  9. Citron DM, Ostovari MI, Karlsson A, Goldstein EJC et al (1991) Evaluation of the E-test for susceptibility testing of anaerobic bacteria. J Clin Microbiol 29:2197–2203
  10. Rosenblatt JE, Gustafson DR (1995) Evaluation of the Etest for the susceptibility testing of anaerobic bacteria. Diagn Microbiol Infect Dis 22:279–284
  11. Citron DM, Hecht DW (2007) Susceptibility test methods: anaerobic bacteria. In: Murray PR, Baron JE, Jorgensen JH et al (eds) Manual of clinical microbiology, 9th edn. American Society Microbiology Press, Washington, DC, pp 1214–1222
  12. Clinical and Laboratory Standards Institute (2007) Methods for antimicrobial susceptibility testing of anaerobic bacteria, 7th edn. Approved Standard, Document M11-A7. CLSI, Wayne, PA
  13. Bolmström A, Karlsson A, Engelhardt A et al (2007) Validation and reproducibility assessment of tigecycline MIC determinations by Etest. J Clin Microbiol 45:2474–2479
  14. Wybo I, Piérard D, Verschraegen I et al (2007) Third Belgian multicentre survey of antibiotic susceptibility of anaerobic bacteria. J Antimicrob Chemother 59:132–139
  15. Papaparaskevas J, Pantazatou A, Katsandri A et al (2008) Moxifloxacin resistance is prevalent among Bacteroides and Prevotella species in Greece. J Antimicrob Chemother 62:137–141
  16. Oten-Iglesias J, Alos JI, Gomez-Garces JL (2002) Increase in resistance to new fluoroquinolones from 1998 to 2001 in the Bacteroides fragilis group. J Antimicrob Chemother 50:1055–1057
  17. Goossens Herman, Ferech Matus, Vander Stichele Robert, Elseviers Monique, Outpatient antibiotic use in Europe and association with resistance: a cross-national database study, 10.1016/s0140-6736(05)17907-0
  18. Betriu C, Culebras E, Gomez M et al (2005) In vitro activity of tigecycline against Bacteroides species. J Antimicrob Chemother 56:349–352